FSH and LH serum/tumor fluid ratios and malignant tumors of the ovary

Endocrine-Related Cancer

Volumn 11, Issue 2, 2004, Pages 315-321

  Rzepka Gorska I ^a,b   Chudecka Glaz A ^a   Kosmowska, B ^a  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

^b NONE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

FOLLITROPIN; LUTEINIZING HORMONE;

ARTICLE; CANCER STAGING; CYSTADENOMA; DIAGNOSTIC VALUE; FEMALE; FOLLITROPIN BLOOD LEVEL; HUMAN; HUMAN TISSUE; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; OVARY CANCER; OVARY CYST; OVARY TUMOR; POSTMENOPAUSE; PREMENOPAUSE; SENSITIVITY AND SPECIFICITY;

ADENOCARCINOMA, MUCINOUS; ADULT; AGED; ASCITIC FLUID; CARCINOMA; CARCINOMA, ENDOMETRIOID; CYST FLUID; CYSTADENOCARCINOMA, SEROUS; DIAGNOSIS, DIFFERENTIAL; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; LUTEINIZING HORMONE; MIDDLE AGED; OVARIAN CYSTS; OVARIAN NEOPLASMS; SENSITIVITY AND SPECIFICITY;

EID: 3042540694     PISSN: 13510088     EISSN: None     Source Type: Journal    
DOI: 10.1677/erc.0.0110315     Document Type: Article

References (33)

1. Abu-Jadweh GM, Faix JD, Niloff J, Tognazzi K, Manseau E, Dvorak HF & Brown LF 1996 Strong expression of vascular peremeability factor (vascular endothelial growth factor) and its receptors in ovarian borderline and malignant neoplasms. Laboratory Investigations 74 1105-1115.
2. Adelson MD & Reece MT 1993 Effects of gonadotropin-releasing hormone analogues on ovarian epithelial tumors. Clinical Obstetrics and Gynecology 36 690-700.
3. Dietrich M, Osmers RG, Grobe G, Zech G, Suren A, Krauss T, Sander H, Fischer G & Kuhn W 1999 Limitations of the evaluation of adnexal masses by its macroscopic aspects, cytology and biopsy. European Journal of Obstetrics and Gynecology and Reproductive Biology 82 59-62.
4. Emons G, Ortmann O, Becker M, Irmer G, Springer B, Laun R, Holzel F, Schultz KD & Schally AV 1993 High affinity binding and direct antiproliferative effects of LHRH analogues in human ovarian cancer cell lines. Cancer Research 53 5439-5446.
5. Emons G, Ortmann O, Teichert HM, Fassl H, Lohrs U, Kullander S, Kauppila A, Ayalon D, Schally A & Oberhauser F 1996 Luteinizing hormone-releasing hormone agonist triptorelin in combination with cytotoxic chemotherapy in patients with advanced ovarian carcinoma. A prospective double-blind randomized trial. Cancer 78 1452-1460.
6. Emons G, Westphalen S, Schultz KD, Schnaars Y, Riethmuller-Winzen H, Verschraegen C & Kavanagh JJ 1999 First results of the GnRH-antagonist Cetrorelix in patients with ovarian cancer. Gynecologic Endocrinology 13 32.
7. Emons G, Weis S, Ortmann O, Grundker C & Schultz KD 2000 LHRH might act as negative autocrine regulator of proliferation of human ovarian cancer. European Journal of Endocrinology 142 665-670.
8. Felberbaum RE, Ludwig M & Diedrich K 2000 Clinical application of GnRH-antagonists. Molecular and Cellular Endocrinology 166 9-14.
9. Górski B, Byrski T, Huzarski T, Jakubowska A, Menkiszak J, Gronwald J, Pluzanska A, Bebenek M, Fischer-Maliszewska L, Grzybowska E, Narod SA & Lubinski J 2000 Founder mutations in the BRCA1 gene in Polish families with breast-ovarian cancer. American Journal of Human Genetics 66 1963-1968.
10. Hazelton D, Nicosia RF & Nicosia SV 1999 Vascular endothelial growth factor levels in ovarian cyst fluid correlate with malignancy. Clinical Cancer Research 5 823-829.
11. Imai A, Ohno T, Iida K, Fuseya T, Furui T & Tamaya T 1994 Gonadotropin-releasing hormone receptor in gynecologic tumors. Frequent expression in adenocarcinoma histologic types. Cancer 74 2555-2561.
12. Irmer G, Burger C, Muller R, Ortmann O, Peter U, Kakar SS, Neill JD, Schultz KD & Emons G 1995 Expression of the messenger RNAs for luteinizing hormone releasing hormone (LHRH) and its receptor in human ovarian epithelial carcinoma. Cancer Research 55 817-822.
13. Kakar SS, Grizzle WE & Neill JD 1994 The nucleotide sequences of human GnRH receptors in breast and ovarian tumors are identical with that found in pituitary. Molecular and Cellular Endocrinology 106 145-149.
14. Kim JH, Park DC, Kim JW, Choi YK, Lew YO, Kim DH, Jung JK, Lim YA & Namkoong SE 1999 Antitumor effect of GnRH agonist in epithelial ovarian cancer. Gynecologic Oncology 74 170-180.
15. Kramer S, Leeker M & Jager W 1998 Gonadotropin levels in ovarian cyst fluids: a predictor of malignancy? International Journal of Biological Markers 13 165-168.
16. Kurbacher CM, Jager W, Kurbacher JA, Bittl A, Wildt L & Lang N 1995 Influence of human luteinizing hormone on cell growth and Ca 125 secretion of primary epithelial ovarian carcinoma in vitro. Tumor Biology 16 374-384.
17. Kuroda H, Mandai M, Konishi I, Yura Y, Tsuruta Y, Hamid AA, Nanbu K, Matsushita K & Mori T 1998 Human chorionic gonadotropin (hCG) inhibits cisplatin-induced apoptosis in ovarian cancer cells: possible role of upregulation of insulin-like growth factor-I by hCG. International Journal of Cancer 76 571-578.
18. Lind MJ, Cantwell BMJ, Millward MJ, Robinson A, Proctor M, Simmons D, Carmichael J & Harris AL 1992 A phase II trial of goserelin (Zoladex) in relapsed epithelial ovarian cancer. British Journal of Cancer 65 621-623.
19. Mandai M, Konishi I, Kuroda H, Fukumoto T, Komatsu T, Yamamoto S, Nanbu K, Rao ChV & Mori T 1997 Messenger ribonucleic acid expression of LH/hCG receptor gene in human ovarian carcinomas. European Journal of Cancer 33 1501-1507.
20. Martinez-Onsubre P, Ruiz Villaespesa A, Sanz Anquela JM & Valenzuela Ruiz PL 2001 Aspiration cytology of 147 adnexal cysts with histologic correlation. Acta Cytologica 45 941-947.
21. Modesit SC, Pavlik EJ, Ueland FR, DePriest PD, Kryscio RJ & van Nagell JR Jr 2003 Risk of malignancy in unilocular ovarian cystic tumors less than 10 centimeters in diameter. Obstetrics and Gynecology 102 594-599.
22. Ohno T, Imai A, Furui T, Takahashi K & Tamaya T 1993 Presence of gonadotropin-releasing hormone and its messenger ribonucleic acid in human ovarian epithelial carcinoma. American Journal of Obstetrics and Gynecology 169 605-610.
23. Ohtani K, Sakamoto H, Kikuchi A, Nakayama Y, Idei T, Igarashi N, Matukawa T & Satoh K 2001 Follicle-stimulating hormone promotes the growth of human epithelial ovarian cancer cells through the protein kinase C-mediated system. Cancer Letters 166 207-213.
24. Oleszczuk J, Lesczńska-Gorzelak B, Kamiński K & Baranowski W 2002 Evaluation of ovarian cysts by means of transabdominal fine needle aspiration or laparotomy in pregnant women. Ginekologia Polska 73 367-370.
25. Parrot JA, Doraiswamy V, Kim G, Mosher R & Skinner MK 2001 Expression and actions of both the follicle stimulating hormone receptor and the luteinizing hormone receptor in normal ovarian surface epithelium and ovarian cancer. Molecular and Cellular Endocrinology 172 213-222.
26. Petrovic N, Arko D, Lovrec VG & Takac I 2002 Ultrasound guided aspiration in pathological adnexal processes. European Journal of Obstetrics and Gynecology and Reproductive Biology 104 52-57.
27. Reimer T, Gerber B, Kunkel S & Luettich K 1997 Estradiol, gonadotropins and tumor markers in ovarian cyst fluid. Acta Obstetrica et Gynecologica Scandinavica 76 478-483.
28. Rzepka-Górska I, Chudecka-Głaz A, Kosmider M & Malecha J 2002 Effectiveness of combined treatment in patients with advanced ovarian carcinoma. Polish Gynecology 73 691-697.
29. Rzepka-Górska I, Chudecka-Głaz A, Kosmider M & Malecha J 2003 GnRH as an adjuvant therapy for ovarian cancer patients. International Journal of Gynecology and Obstetrics 81 199-205.
30. Schiffenbauer YS, Abramovitch R, Meir G, Nevo N, Holzinger M, Itin A, Keshet E & Neeman M 1997 Loss of ovarian function promotes angiogenesis in human ovarian carcinoma. PNAS 94 13203-13208.
31. Schiffenbauer YS, Meir G, Maoz M, Evan-Ram SC, Bar-Shavit R & Neeman M 2002 Gonadotropin stimulation of MLS human epithelial ovarian carcinoma cells augments cell adhesion mediated by CD44 and by alpha(v)-integrin. Gynecologic Oncology 84 296-302.
32. Syed V, Ulifiski G, Mok SC, Yiu GK & Ho SM 2001 Expression of gonadotropin receptor and growth responses to key reproductive hormones in normal and malignant human ovarian surface epithelial cells. Cancer Research 61 6768-6776.
33. Wimalsena J, Dostal R & Meehan D 1992 Gonadotropins, estradiol, and growth factors regulate epithelial ovarian cancer cell growth. Gynecologic Oncology 46 345-350.